Power Law company profile

Axsome Therapeutics

Biotech & Life Sciences · New York City, United States · Founded 2012 · IPO 2015 Unicorn

Axsome Therapeutics develops and commercializes therapies for the management and treatment of pain and other neurological disorders

Valuation

$11B

Market cap · May/2026

Revenue

$638M

Latest reported FY

EBITDA

$42M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where Axsome Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · New York City HQ

Book a demo for the full country breakdown

Web traffic by country

32K monthly visits
across markets

🇺🇸 United States61.9%

🇨🇦 Canada6.6%

🇬🇧 United Kingdom5%

🇮🇳 India3.4%

🏳️ Korea2.5%

Top 5 markets shown

Market sentiment

What the market is saying about Axsome Therapeutics

An AI-synthesized read of the highest-engagement posts about Axsome Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Axsome Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles